Friedrich Kühn1, Charlotte Emmi Elisabeth Simon2, Ilhamiyya Aliyeva1, Julia KUßMAUL1, Jessica GROß1, Oliver Schweizerhof3,4, Jens-Uwe Blohmer1, Maria Margarete Karsten5. 1. Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Clinic for Gynecology with Breast Center, Berlin, Germany. 2. Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany. 3. Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Biometry and Clinical Epidemiology, Berlin, Germany. 4. Berlin Institute of Health (BIH), Berlin, Germany. 5. Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Clinic for Gynecology with Breast Center, Berlin, Germany maria-margarete.karsten@charite.de.
Abstract
BACKGROUND: Exact localization of non-palpable breast lesions is necessary to ensure that the correct lesion is removed. Conventional methods come with several disadvantages. PATIENTS AND METHODS: We compared 28 patients who underwent breast-conserving surgery for a non-palpable lesion. By surgeon choice, 14 patients were assigned to undergo magnetic seed localization and 14 underwent standard wire localization. The primary outcome was the operative time, and secondary outcome was the patient pain level. RESULTS: The mean age was 52±10 (SD) years in the seed arm, and 55±13 years in the wire arm. The median time from skin incision to tumor extraction was not significantly different between the two groups. Patients in the wire localized group significantly more often reported pain during coughing/breathing, movement, and sleep. CONCLUSION: Using seed localization at Charité Breast Center did not lead to a significant decrease in operative time but might allow time savings once established, while increasing patient comfort and reducing organizational burden. Copyright
BACKGROUND: Exact localization of non-palpable breast lesions is necessary to ensure that the correct lesion is removed. Conventional methods come with several disadvantages. PATIENTS AND METHODS: We compared 28 patients who underwent breast-conserving surgery for a non-palpable lesion. By surgeon choice, 14 patients were assigned to undergo magnetic seed localization and 14 underwent standard wire localization. The primary outcome was the operative time, and secondary outcome was the patientpain level. RESULTS: The mean age was 52±10 (SD) years in the seed arm, and 55±13 years in the wire arm. The median time from skin incision to tumor extraction was not significantly different between the two groups. Patients in the wire localized group significantly more often reported pain during coughing/breathing, movement, and sleep. CONCLUSION: Using seed localization at Charité Breast Center did not lead to a significant decrease in operative time but might allow time savings once established, while increasing patient comfort and reducing organizational burden. Copyright
Authors: Alexandra Simbrich; Ina Wellmann; Jan Heidrich; Oliver Heidinger; Hans-Werner Hense Journal: Cancer Epidemiol Date: 2016-07-25 Impact factor: 2.984
Authors: Erica V Bloomquist; Nicolas Ajkay; Sujata Patil; Abigail E Collett; Thomas G Frazier; Andrea V Barrio Journal: Breast J Date: 2015-12-23 Impact factor: 2.431
Authors: Heather I Greenwood; Jasmine M Wong; Rita A Mukhtar; Michael D Alvarado; Elissa R Price Journal: AJR Am J Roentgenol Date: 2019-06-05 Impact factor: 3.959
Authors: James O Murphy; Tracy-Ann Moo; Tari A King; Kimberly J Van Zee; Kristine A Villegas; Michelle Stempel; Anne Eaton; Jean M St Germain; Elizabeth Morris; Monica Morrow Journal: Ann Surg Oncol Date: 2013-08-14 Impact factor: 5.344
Authors: Benjamin K Y Chan; Jill A Wiseberg-Firtell; Ramesh H S Jois; Katrin Jensen; Riccardo A Audisio Journal: Cochrane Database Syst Rev Date: 2015-12-31
Authors: James R Harvey; Yit Lim; John Murphy; Miles Howe; Julie Morris; Amit Goyal; Anthony J Maxwell Journal: Breast Cancer Res Treat Date: 2018-02-16 Impact factor: 4.872